BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23820625)

  • 1. Costs of diabetes and its complications in Poland.
    Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
    Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
    van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
    Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current total economic burden of diabetes mellitus in the Netherlands.
    Peters ML; Huisman EL; Schoonen M; Wolffenbuttel BHR
    Neth J Med; 2017 Sep; 75(7):281-297. PubMed ID: 28956787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach.
    Marcellusi A; Viti R; Mecozzi A; Mennini FS
    Eur J Health Econ; 2016 Mar; 17(2):139-47. PubMed ID: 25427540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The direct and indirect costs of epilepsy in Poland estimates for 2014-2016 years.
    Mela A; Staniszewska A; Wrona W; Poniatowski ŁA; Jaroszyński J; Niewada M
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):353-362. PubMed ID: 30293466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017-2019.
    Seweryn M; Banas T; Augustynska J; Lorenc O; Kopel J; Pluta E; Skora T
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Impact of Diabetes in Africa.
    Mapa-Tassou C; Katte JC; Mba Maadjhou C; Mbanya JC
    Curr Diab Rep; 2019 Jan; 19(2):5. PubMed ID: 30680578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost of diabetes mellitus in Spain].
    González P; Faure E; Del Castillo A;
    Med Clin (Barc); 2006 Nov; 127(20):776-84. PubMed ID: 17198665
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States.
    Foos V; Varol N; Curtis BH; Boye KS; Grant D; Palmer JL; McEwan P
    J Med Econ; 2015 Jun; 18(6):420-32. PubMed ID: 25629654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates.
    Al-Maskari F; El-Sadig M; Nagelkerke N
    BMC Public Health; 2010 Nov; 10():679. PubMed ID: 21059202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect costs of diabetes and its impact on the public finance: the case of Poland.
    Torój A; Mela A
    Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):93-105. PubMed ID: 28796563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A total cost perspective of type 1 and 2 diabetes mellitus in two South African medical schemes servicing the public healthcare sector.
    Opperman AM; De Klerk M
    S Afr Med J; 2021 Jun; 111(7):635-641. PubMed ID: 34382546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
    Javanbakht M; Baradaran HR; Mashayekhi A; Haghdoost AA; Khamseh ME; Kharazmi E; Sadeghi A
    PLoS One; 2011; 6(10):e26864. PubMed ID: 22066013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term societal economic burden of first-incident type 2 diabetes-related complications - a nationwide cohort study.
    Kjellberg J; Tikkanen CK; Bagger M; Gæde P
    Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):577-586. PubMed ID: 33054434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes and healthcare resource utilisation in the Kingdom of Bahrain.
    Salman RA; AlSayyad AS; Ludwig C
    BMC Health Serv Res; 2019 Dec; 19(1):939. PubMed ID: 31805932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic costs of diabetes in the US in 2002.
    Hogan P; Dall T; Nikolov P;
    Diabetes Care; 2003 Mar; 26(3):917-32. PubMed ID: 12610059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis.
    Cheng SW; Wang CY; Chen JH; Ko Y
    Medicine (Baltimore); 2018 Aug; 97(31):e11602. PubMed ID: 30075532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.